drugset / Trial / NCT07141199
A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
The objective of this study is to assess the safety, tolerability, pharmacokinetics, and immunogenicity following multiple intravenous (IV) ascending doses of ABBV-8736 in healthy adult participants.
Timeline
- Start
- 2025-09-02
- Primary completion
- 2026-03-23
- Completion
- 2026-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-8736 | Unknown | — | Intravenous |
Indications
No indication recorded.